ÀÌÅ»¸®¾Æ ´Ù±¹Àû ¹ÙÀÌ¿À Á¦¾àȸ»ç ¸Þ³ª¸®´ÏÀÇ Çѱ¹¹ýÀÎÀÎ Çѱ¹¸Þ³ª¸®´Ï¢ß(´ëÇ¥ ¹ÚÇý¿µ)´Â ÃÖ±Ù BENEFIT(BEnefits after 24 weeks of Nebivolol administration For essential hypertensIon patients wiTh various comorbidities and treatment environments in Korea) ¿¬±¸¸¦ ÅëÇØ È®ÀÎµÈ °íÇ÷¾Ð Ä¡·á¿¡ ÀÖ¾î¼ ³×ºñ·¹Æ®(¼ººÐ¸í: ³×ºñº¸·Ñ)ÀÇ È¿°ú¿Í ÃֽŠÁö°ßÀ» °øÀ¯ÇÏ´Â ‘BENEFIT Regional Hybrid Symposium’À» °³ÃÖÇß´Ù.
À̹ø ½ÉÆ÷Áö¾öÀº Äڷγª19ÀÇ ¿µÇâÀ¸·Î ¿Â¶óÀÎÀ¸·Î ÁøÇàµÇ¾úÀ¸¸ç, °íÇ÷¾Ð Ä¡·á¿¡ °ü½ÉÀÌ ¸¹Àº Á¾ÇÕº´¿ø ¹× °³¿ø°¡ ÀÇ·áÁøÀÌ Âü¼®ÇÑ °¡¿îµ¥ 2°³ÀÇ ¼¼¼ÇÀ¸·Î ÁøÇàµÆ´Ù.
½ÅÁøÈ£ ÇѾç´ëÇб³º´¿ø ½ÉÀå³»°ú ±³¼ö°¡ ÁÂÀåÀ» ¸Ã°í È«½ÂÇ¥ ´ë±¸°¡Å縯´ëÇб³º´¿ø ¼øȯ±â³»°ú ±³¼ö¿Í Ȳ¿ø¹Î °Ç¾ç´ëÇб³º´¿ø ½ÅÀå³»°ú ±³¼ö°¡ °¢°¢ BENEFIT-KOREA ¿¬±¸°á°ú ¹× ÀÓ»ó Àû¿ë(Lesson from BENEFIT Korea Study and clinical application), ½É¹Ú¼ö ¹× °íÇ÷¾Ð Á¶Àý: BENEFIT-KOREA ¿¬±¸°á°ú(Heart rate and hypertension control: Result from BENEFIT-Korea Study)¿¡ ´ëÇØ ¹ßÇ¥Çß´Ù.
È«½ÂÇ¥ ´ë±¸°¡Å縯´ëÇб³º´¿ø ¼øȯ±â³»°ú ±³¼ö´Â “BENEFIT-KOREA ¿¬±¸°á°ú¿¡ µû¸£¸é ³×ºñ·¹Æ®¸¦ º¹¿ëÇÑ °íÇ÷¾Ð ȯÀÚÀÇ Æò±Õ ¼öÃà±â Ç÷¾Ð(SBP)ÀÌ 11mmHg, À̿ϱâ Ç÷¾Ð(DBP)Àº 6.3mmHg °¨¼ÒÇßÀ¸¸ç, °íÇ÷¾Ð Ä¡·á¿¡ ´ëÇÑ È¿°ú¿Í ¾ÈÀü¼ºÀ» È®ÀÎÇÒ ¼ö ÀÖ¾ú´Ù”°í ¸»Çß´Ù. ¶ÇÇÑ, “12ÁÖ¿Í 24ÁÖ ÈÄ À¯ÀǹÌÇÏ°Ô Ç÷¾ÐÀÌ ¶³¾îÁö´Â È¿°ú¸¦ º¸¿´´Ù”°í ¼³¸íÇß´Ù.
Ȳ¿ø¹Î °Ç¾ç´ëÇб³º´¿ø ½ÅÀå³»°ú ±³¼ö´Â “ÃÖ±Ù °íÇ÷¾Ð Ä¡·á¿¡ À־ Ç÷¾Ð °ÇϻӸ¸ ¾Æ´Ï¶ó ½É¹Ú¼ö Á¶ÀýÀ» À§Çؼ °³º°ÈµÈ Ä¡·á°¡ ¿ä±¸µÇ´Âµ¥ ³×ºñ·¹Æ®´Â Ç÷¾Ð °ÇÏ´Â ¹°·Ð ½É¹Ú¼ö¸¦ Á¶ÀýÇϴµ¥ È¿°úÀûÀÌ´Ù”°í ¸»Çß´Ù. “ƯÈ÷ Çѱ¹ÀÎ °íÇ÷¾Ð ȯÀÚ¸¦ ´ë»óÀ¸·Î ³×ºñ·¹Æ® Àú¿ë·®ÀÎ 2.5mgÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» ºÐ¼®ÇÑ °á°ú¿¡¼µµ ¼öÃà±â Ç÷¾Ð(SBP)°ú À̿ϱâ Ç÷¾Ð(DBP)Àº ¹°·Ð ½É¹Ú¼ö(pulse rate)µµ 12ÁÖ¿Í 24ÁÖ ÈÄ ¸ðµÎ À¯ÀÇÇÑ °¨¼Ò¸¦ º¸¿´´Ù”°í ¹àÇû´Ù.
¹ÚÇý¿µ Çѱ¹¸Þ³ª¸®´Ï ´ëÇ¥´Â “Çѱ¹¸Þ³ª¸®´Ï´Â ³×ºñ·¹Æ®ÀÇ ¾ÈÀü¼º ¹× È¿°ú¸¦ µÞ¹ÞħÇÏ´Â ‘BENEFIT-KOREA’ ¿¬±¸ °á°ú¸¦ ±¹³» ÀÇ·áÁøµé¿¡°Ô ³Î¸® ¾Ë¸®°íÀÚ ³ë·ÂÇÏ°í ÀÖ´Ù”¸é¼ “À̸¦ ÅëÇØ ³×ºñ·¹Æ®°¡ ±¹³» °íÇ÷¾Ð ȯÀڵ鿡°Ô À¯¿ëÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇϱ⸦ ±â´ëÇÑ´Ù”°í ¸»Çß´Ù.
ÇÑÆí, ³×ºñ·¹Æ®´Â Àü¼¼°è¿¡¼ °¡Àå ¸¹ÀÌ Æȸ®´Â 3¼¼´ë º£Å¸Â÷´ÜÁ¦(¾ÆÀÌÅ¥ºñ¾Æ ±Û·Î¹ú µ¥ÀÌÅÍ ±âÁØ)·Î ¹Ì±¹, µ¶ÀÏ µî Àü¼¼°è 78°³±¹¿¡¼ ÆǸŠÁßÀ̸ç, ±¹³»¿¡´Â Áö³ 2009³â 6¿ù¿¡ Ãâ½ÃµÆ´Ù. Áö³ ÇØ 12¿ùºÎÅÍ Àú¿ë·® Á¦Ç°ÀÎ ‘³×ºñ·¹Æ®¿¥’ 1.25mg°ú 2.5mg ÆǸŸ¦ ½ÃÀÛÇÏ¸ç ´Ù¾çÇÑ Æ¯¼ºÀÇ ±¹³» °íÇ÷¾Ð ȯÀڵ鿡°Ô À¯¿ëÇÑ Ä¡·á ¿É¼ÇÀ» Á¦°øÇÏ°í ÀÖ´Ù. ¶ÇÇÑ, ÃÖ±Ù ÁøÇàµÈ ¼¼°è°íÇ÷¾ÐÇÐȸ(ISH)¤ýÀ¯·´°íÇ÷¾ÐÇÐȸ(ESH) ÅëÇÕÇмú´ëȸ(Hypertension 2021)¿¡¼ BENEFIT ¼ºê ±×·ì ¿¬±¸ °á°ú¸¦ Æ÷½ºÅÍ ¹ßÇ¥ÇÏ´Â µî ´Ù¾çÇÑ ¿¬±¸¸¦ À̾°í ÀÖ´Ù. |